Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients
NCT00259025
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Renal Failure, Chronic
Interventions
DRUG:
lipid emulsion with a high content of n-3 fatty acids
Sponsor
Aalborg University Hospital